-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TD1Hbgj+tmslymqLHcp6Yfj4D2XN6fcUsa8MC5RkUvSHk+lXIDSFPg2MqaTyJ5Wn fK+PO1WGmE2wSl6fnNd7ng== 0001193125-10-165028.txt : 20100916 0001193125-10-165028.hdr.sgml : 20100916 20100723162224 ACCESSION NUMBER: 0001193125-10-165028 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100723 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trius Therapeutics Inc CENTRAL INDEX KEY: 0001356857 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201320630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-452-0370 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR SUITE 105 CITY: SAN DIEGO STATE: CA ZIP: 92121 CORRESP 1 filename1.htm Acceleration Request

July 23, 2010

Securities and Exchange Commission

Division of Corporate Finance

100 F St., N.E.

Washington, D.C. 20549

Attn: Jeffrey Riedler
   John L. Krug

 

Re: Trius Therapeutics, Inc. (the “Company”)
   Registration Statement on Form S-1
   (File No. 333-162945)

Ladies and Gentlemen:

In connection with the proposed offering of the above-captioned securities, we wish to advise you that we, as a representative of the underwriters, hereby join with the Company’s request that the effective date of the above-captioned Registration Statement be accelerated so that the same will become effective on July 27, 2010 at 4:00 p.m., Eastern Standard Time or as soon as practicable thereafter.

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Securities Act of 1933:

 

(i) Date of preliminary prospectus: July 13, 2010

 

(ii) Approximate dates of distribution: July 13, 2010 to July 22, 2010

 

(iii) Number of prospective underwriters and dealers to whom the preliminary prospectus was furnished: 4

 

(iv) Number of prospectuses so distributed: 6025

 

(v) Compliance with Rule 15c2-8 under the Securities Exchange Act of 1934: Included in Master Agreement Among Underwriters of Citigroup Global Markets Inc.

 

Very truly yours,

/s/ Eric W. Wooley

Citigroup Global Markets Inc.
Eric W. Wooley
Director
 -----END PRIVACY-ENHANCED MESSAGE-----